Trials / Completed
CompletedNCT04680143
Systemic Erythropoietin Injection in Patients Having Optic Atrophy
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Alexandria University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this treatment trial is to study the effect of systemic erythropoietin in patients having optic atrophy.
Detailed description
The purpose of this treatment trial is to study the effect of systemic erythropoietin in patients having optic atrophy. The intervention is systemic erythropoietin injections (eprax 10000 IU subcutaneous twice daily for three days). Follow up after one month and three months by recording visual acuity and electro physiological studies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Systemic erythropoietin injection | Systemic erythropoietin injections (eprax 10000 IU subcutaneous twice daily for three days). |
Timeline
- Start date
- 2020-09-01
- Primary completion
- 2021-03-01
- Completion
- 2021-03-30
- First posted
- 2020-12-22
- Last updated
- 2021-07-13
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04680143. Inclusion in this directory is not an endorsement.